Frequently asked questions (FAQ)

The National COVID Cancer Survey will help to understand the protection provided by antibodies generated following COVID-19 infection and vaccination. It will also provide crucial insight to aid wider efforts to safeguard, protect and monitor those living with and beyond cancer.

You can find out the answers to some of the frequently asked questions below: